Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Change in Taxes (2021 - 2022)

Cartesian Therapeutics (RNAC) has disclosed Change in Taxes for 2 consecutive years, with -$321000.0 as the latest value for Q3 2022.

  • On a quarterly basis, Change in Taxes fell 102.03% to -$321000.0 in Q3 2022 year-over-year; TTM through Jun 2023 was -$321000.0, a 200.0% decrease, with the full-year FY2022 number at -$601000.0, down 200.0% from a year prior.
  • Change in Taxes was -$321000.0 for Q3 2022 at Cartesian Therapeutics, down from $1000.0 in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $15.8 million in Q3 2021 to a low of -$15.2 million in Q4 2021.